Author:
Burns L J,Weisdorf D J,DeFor T E,Vesole D H,Repka T L,Blazar B R,Burger S R,Panoskaltsis-Mortari A,Keever-Taylor C A,Zhang M-J,Miller J S
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference42 articles.
1. Weisdorf DJ, Verfaillie CM, Miller WJ et al. Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective, comparative trial. Am J Hematol 1997; 54: 202–208.
2. Antman KH, Rowlings PA, Vaughan WP et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 1992; 15: 1870–1879.
3. Verma UN, Areman E, Dickerson SA et al. Interleukin-2 activation of chemotherapy and growth factor-mobilized peripheral blood stem cells for generation of cytotoxic effectors. Bone Marrow Transplant 1995; 15: 199–206.
4. Miller JS, Tessmer-Tuck J, Pierson BA et al. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity. Biol Blood Marrow Transplant 1997; 3: 34–44.
5. Gottlieb DJ, Brenner MK, Heslop HE et al. A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease. Br J Cancer 1989; 60: 610.
Cited by
204 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献